NASDAQ:VIR
Vir Biotechnology, Inc. Stock News
$9.75
-0.610 (-5.89%)
At Close: Jun 14, 2024
Vir Biotechnology, Inc. (VIR) Moves 14.8% Higher: Will This Strength Last?
07:10pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Vir Biotechnology, Inc. (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further streng
Vir Biotechnology, Inc. (VIR) Moves 14.8% Higher: Will This Strength Last?
04:33pm, Thursday, 31'st Mar 2022
Vir Biotechnology, Inc. (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further streng
VIR Stock Gains on News of Inclusion in the S&P SmallCap 600
03:23pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Vir Biotechnology (VIR) shares gain as the company is set to join the S&P SmallCap 600 effective prior to the opening of trading on Monday, Apr 4.
VIR Stock Gains on News of Inclusion in the S&P SmallCap 600
12:47pm, Thursday, 31'st Mar 2022
Vir Biotechnology (VIR) shares gain as the company is set to join the S&P SmallCap 600 effective prior to the opening of trading on Monday, Apr 4.
Vir Jumps 20% On S&P SmallCap 600 News
12:25pm, Thursday, 31'st Mar 2022
Currently, 66 ETFs are affected, but it will be added to even more funds soon.
Dow, S&P 500 snap four-session win streak as stocks close lower on fading Ukraine optimism
08:14pm, Wednesday, 30'th Mar 2022 MarketWatch
Wall Street ends lower on a modest pullback Wednesday, as investors check their optimism over negotiations between Ukraine and Russia.
Why Vir Biotechnology Stock Is Skyrocketing Today
04:40pm, Wednesday, 30'th Mar 2022 The Motley Fool
The S&P SmallCap 600 index will soon include Vir.
Why Vir Biotechnology Stock Is Skyrocketing Today
12:40pm, Wednesday, 30'th Mar 2022
The S&P SmallCap 600 index will soon include Vir.
These 2 Nasdaq Biotech Stocks Are Soaring Wednesday Morning
12:24pm, Wednesday, 30'th Mar 2022 The Motley Fool
Markets looked to take a breather after a huge surge in recent weeks.
Vir's stock is up 12% after news it will join the S&P SmallCap 600
09:31am, Wednesday, 30'th Mar 2022
Shares of Vir Biotechnology Inc. VIR, +15.99% were up 12.8% in premarket trading on Wednesday, the day after it was announced that the stock will join the S&P SmallCap 600 SML, -0.20% , effective Apri
AstraZeneca (AZN) Gets EU Nod for COVID-19 Antibody Cocktail
04:31pm, Monday, 28'th Mar 2022 Zacks Investment Research
The European Commission approves AstraZeneca's (AZN) Evusheld for the pre-exposure prophylaxis of COVID-19 infection in a broad patient population.
FDA Revises EUA of Glaxo (GSK) & Vir's (VIR) COVID Therapy
03:41pm, Monday, 28'th Mar 2022 Zacks Investment Research
The FDA restricts the use of sotrovimab, Glaxo (GSK)/Vir's (VIR) COVID therapy, in several states and territories based on the latest data that does not support the therapy's effectiveness against a d
FDA Revises EUA of Glaxo (GSK) & Vir's (VIR) COVID Therapy
12:48pm, Monday, 28'th Mar 2022
The FDA restricts the use of sotrovimab, Glaxo (GSK)/Vir's (VIR) COVID therapy, in several states and territories based on the latest data that does not support the therapy's effectiveness against a d
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
10:47am, Monday, 28'th Mar 2022
The FDA said that the currently authorized 500mg dose of GlaxoSmithKline Plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 antibody therapy is unlikely to be effective against th
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
08:04pm, Friday, 25'th Mar 2022 GlobeNewswire Inc.
SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the US Food and Drug Administration has amended t
